Tesla’s 10% Weight in ARKK Sets Up a Make-or-Break Year for the Innovation ETF

The ARK Innovation ETF (NYSEARCA:ARKK) has barely moved this year, gaining about 2% year to date through late June and sitting at roughly $78 per share. That stasis hides a violent tug of war inside the portfolio: AMD has more than doubled, up 144% YTD, while Coinbase has shed 34% and Tesla (NASDAQ:TSLA | TSLA Price Prediction), ARKK’s largest holding, is down 16%. For a fund whose $6.48 billion in net assets is built on long-duration disruptive innovation bets, the next twelve months will be decided by the path of long-duration discount rates and the trajectory of Tesla.

The fund’s current shape

Cathie Wood’s flagship is an actively managed bet on profitless or marginally profitable growth, and the April NPORT filing shows the concentration is meaningful. Tesla alone accounts for roughly 10% of assets, followed by Tempus AI at 5%, AMD at 5%, and CRISPR Therapeutics at 5%. The top ten names make up roughly 49% of the portfolio, including a 2.7% private stake in OpenAI Series C valued at $175 million. The one-year return trails what most diversified tech baskets delivered, leaving ARKK’s five-year record at negative 37%.

The macro signal: the 10-year Treasury yield

ARKK’s holdings throw off little to no current earnings. CRISPR posted $1.46 million in Q1 revenue against a $130 million operating loss, and CoreWeave generated a $740 million net loss on $7.7 billion in capex. Valuations of names like these move almost mechanically with the discount rate applied to cash flows a decade out, which makes the 10-year Treasury yield the single most important variable to track.

The 10-year currently sits at 4.40%, down from a May 19 peak of 4.67% but still in the 79th percentile of its 12-month range. The Fed has held the upper bound at 3.75% for six months after cutting 75 basis points between October and December 2025. Watch the FRED DGS10 series weekly: a sustained move back above 4.60% would compress multiples on the genomics and fintech sleeves where roughly a third of ARKK lives, while a break below 4.00%, last seen on February 27, has historically been the green light for unprofitable growth to rerate higher. The yield curve adds nuance: the 2s10s spread has compressed from 0.74% in February to 0.31%, a flattening that tends to precede growth scares.

The fund-specific signal: Tesla’s outsized weight

No single position matters more to ARKK than Tesla. At roughly 10% of net assets, $631 million, it is nearly twice the size of the next-largest holding and double the average top-ten weight. Tesla’s 14% drop over the past month alone has been enough to neutralize gains from other top holdings. Wood’s long-standing robotaxi thesis values the company on autonomy revenue that has not yet materialized, so any quarterly delivery report or Full Self-Driving milestone flows directly into the fund’s NAV.

The secondary fund-specific issue is the crypto-adjacent cluster: Coinbase (4%), Robinhood (4%), Circle (4%), and Bullish (2%) together approach 15% of assets. Coinbase just posted a $394 million GAAP loss tied to $482 million in crypto asset markdowns, and Circle’s reserve return rate fell 66 basis points to 3.5% as rates eased. Investors holding ARKK for AI exposure should recognize they are also underwriting a leveraged bet on the next crypto cycle.

What to watch next

If the 10-year Treasury yield breaks below 4.00% before the September FOMC meeting, ARKK’s biotech and fintech sleeves should rerate sharply higher. The fund-specific trigger to monitor is the next ARK weekly trade disclosure for Tesla: any meaningful trim of that 9.74% position would signal Wood’s own conviction is shifting, while continued accumulation tells you she is doubling down on the single bet that drives the fund’s fate.